
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $2.3B | $2.6B | $2.8B | $2.8B | $2.8B | |
Revenue Growth (YoY) | -2.44% | 8.85% | 8.65% | 1.49% | -1.74% | |
Cost of Revenues | $1.8B | $1.9B | $2.1B | $2.1B | $2.1B | |
Gross Profit | $595.3M | $650.8M | $674.8M | $678.9M | $645.6M | |
Gross Profit Margin | 25.38% | 25.49% | 24.32% | 24.11% | 23.33% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $527.4M | $508M | $534.9M | $533.4M | $496.5M | |
Other Inc / (Exp) | $1.3M | $2.7M | -$15.5M | -$6.7M | $45.6M | |
Operating Expenses | $583.2M | $560.3M | $586.4M | $577.9M | $532.3M | |
Operating Income | $12.1M | $90.5M | $88.4M | $101M | $113.3M | |
Net Interest Expenses | $64.6M | $42.3M | $53.3M | $97.4M | $62.4M | |
EBT. Incl. Unusual Items | -$51.2M | $50.9M | $19.6M | -$3.1M | $96.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$9.6M | $4.6M | $5.6M | $4.6M | $30.1M | |
Net Income to Company | -$41.6M | $46.3M | $14M | -$7.7M | $66.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$41.6M | $46.3M | $14M | -$7.7M | $66.4M | |
Basic EPS (Cont. Ops) | -$0.40 | $0.44 | $0.14 | -$0.12 | $0.21 | |
Diluted EPS (Cont. Ops) | -$0.40 | $0.44 | $0.14 | -$0.12 | $0.20 | |
Weighted Average Basic Share | $103.7M | $105.2M | $97.9M | $93.4M | $94.7M | |
Weighted Average Diluted Share | $103.7M | $105.7M | $98.2M | $93.4M | $96.1M | |
EBITDA | $149.7M | $230.2M | $223.3M | $244M | $303.1M | |
EBIT | $13.4M | $93.2M | $72.9M | $94.3M | $158.9M | |
Revenue (Reported) | $2.3B | $2.6B | $2.8B | $2.8B | $2.8B | |
Operating Income (Reported) | $12.1M | $90.5M | $88.4M | $101M | $113.3M | |
Operating Income (Adjusted) | $13.4M | $93.2M | $72.9M | $94.3M | $158.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $651.9M | $711.9M | $650.4M | $672.9M | $662.6M | |
Revenue Growth (YoY) | 16.6% | 9.2% | -8.64% | 3.46% | -1.53% | |
Cost of Revenues | $493.8M | $554.8M | $503.3M | $520.9M | $515.1M | |
Gross Profit | $158.1M | $157.1M | $147.1M | $152M | $147.5M | |
Gross Profit Margin | 24.25% | 22.07% | 22.62% | 22.59% | 22.26% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $127.9M | $133.4M | $138.7M | $125M | $118.1M | |
Other Inc / (Exp) | $500K | -$1M | $600K | $44.7M | -$800K | |
Operating Expenses | $140.4M | $145.4M | $149.7M | $133.7M | $125.2M | |
Operating Income | $17.7M | $11.7M | -$2.6M | $18.3M | $22.3M | |
Net Interest Expenses | $9.6M | $10.1M | $27.7M | $16M | $12.8M | |
EBT. Incl. Unusual Items | $8.6M | $600K | -$29.7M | $47M | $8.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.3M | -$100K | -$7.7M | $13.3M | $2.3M | |
Net Income to Company | $6.3M | $700K | -$22M | $33.7M | $6.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $6.3M | $700K | -$22M | $33.7M | $6.4M | |
Basic EPS (Cont. Ops) | $0.06 | $0.01 | -$0.23 | $0.17 | -$0.03 | |
Diluted EPS (Cont. Ops) | $0.06 | $0.01 | -$0.23 | $0.17 | -$0.03 | |
Weighted Average Basic Share | $105.2M | $100.3M | $93.5M | $94.4M | $95.5M | |
Weighted Average Diluted Share | $105.7M | $100.6M | $93.5M | $95.7M | $95.5M | |
EBITDA | $51.4M | $47.2M | $36.4M | $97.8M | $60.5M | |
EBIT | $18.2M | $10.7M | -$2M | $63M | $21.5M | |
Revenue (Reported) | $651.9M | $711.9M | $650.4M | $672.9M | $662.6M | |
Operating Income (Reported) | $17.7M | $11.7M | -$2.6M | $18.3M | $22.3M | |
Operating Income (Adjusted) | $18.2M | $10.7M | -$2M | $63M | $21.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.4B | $2.7B | $2.8B | $2.8B | $2.7B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.8B | $2B | $2.1B | $2.1B | $2.1B | |
Gross Profit | $611.7M | $656.1M | $672.5M | $670M | $634.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $521.4M | $525M | $543M | $511.9M | $479M | |
Other Inc / (Exp) | $4.5M | $400K | -$13.7M | $37.7M | -$900K | |
Operating Expenses | $576.6M | $576.3M | $591.9M | $552.3M | $511.2M | |
Operating Income | $35.1M | $79.8M | $80.6M | $117.7M | $122.9M | |
Net Interest Expenses | $53.3M | $39M | $84.5M | $79.6M | $56.3M | |
EBT. Incl. Unusual Items | -$13.7M | $41.2M | -$17.6M | $75.8M | $65.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $500K | $1.3M | -$2.8M | $25.3M | $20.6M | |
Net Income to Company | -$14.2M | $39.9M | -$14.8M | $50.5M | $45.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$14.2M | $39.9M | -$14.8M | $50.5M | $45.1M | |
Basic EPS (Cont. Ops) | -$0.13 | $0.39 | -$0.15 | $0.22 | -$0.02 | |
Diluted EPS (Cont. Ops) | -$0.13 | $0.38 | -$0.15 | $0.22 | -$0.02 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $178M | $219.8M | $223.4M | $298.2M | $273.2M | |
EBIT | $39.6M | $80.2M | $66.9M | $155.4M | $122M | |
Revenue (Reported) | $2.4B | $2.7B | $2.8B | $2.8B | $2.7B | |
Operating Income (Reported) | $35.1M | $79.8M | $80.6M | $117.7M | $122.9M | |
Operating Income (Adjusted) | $39.6M | $80.2M | $66.9M | $155.4M | $122M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $914.6M | $1B | $1B | $1B | $987.5M | |
Gross Profit | $291.7M | $297M | $294.7M | $285.8M | $274.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $251.2M | $268.3M | $276.3M | $254.9M | $237.4M | |
Other Inc / (Exp) | $1.9M | -$300K | $1.3M | $45.9M | -$600K | |
Operating Expenses | $277.6M | $293.7M | $299.2M | $273.7M | $252.6M | |
Operating Income | $14.1M | $3.3M | -$4.5M | $12.1M | $21.7M | |
Net Interest Expenses | $23.2M | $19.8M | $50.9M | $33.1M | $27M | |
EBT. Incl. Unusual Items | -$7.2M | -$16.8M | -$54.1M | $24.9M | -$5.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$1.5M | -$4.7M | -$13.2M | $7.6M | -$1.9M | |
Net Income to Company | -$5.7M | -$12.1M | -$40.9M | $17.3M | -$4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$5.7M | -$12.1M | -$40.9M | $17.3M | -$4M | |
Basic EPS (Cont. Ops) | -$0.05 | -$0.11 | -$0.43 | -$0.10 | -$0.23 | |
Diluted EPS (Cont. Ops) | -$0.05 | -$0.11 | -$0.43 | -$0.10 | -$0.23 | |
Weighted Average Basic Share | $210.3M | $205.5M | $186.7M | $188.4M | $190.7M | |
Weighted Average Diluted Share | $210.8M | $205.9M | $186.7M | $189.7M | $190.7M | |
EBITDA | $84.7M | $74.3M | $74.2M | $128.5M | $98.6M | |
EBIT | $16M | $3M | -$3.2M | $58M | $21.1M | |
Revenue (Reported) | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B | |
Operating Income (Reported) | $14.1M | $3.3M | -$4.5M | $12.1M | $21.7M | |
Operating Income (Adjusted) | $16M | $3M | -$3.2M | $58M | $21.1M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $157.1M | $123.7M | $20.1M | $67M | $140.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $319.2M | $378.9M | $397.6M | $442.3M | $415.2M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $62.2M | $97M | $129.2M | $89.3M | $86.7M | |
Total Current Assets | $633.1M | $710.8M | $677.1M | $742.1M | $780.1M | |
Property Plant And Equipment | $310.3M | $333.9M | $409.9M | $401.3M | $473.2M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $1.9B | $2B | $2B | $2B | $2B | |
Other Intangibles | $221.3M | $197.6M | $174.3M | $132.3M | $95.8M | |
Other Long-Term Assets | $47M | $44.5M | $35.4M | $55.1M | $27M | |
Total Assets | $3.1B | $3.2B | $3.3B | $3.4B | $3.4B | |
Accounts Payable | $116.8M | $144.4M | $151.2M | $136.2M | $144.1M | |
Accrued Expenses | $197.2M | $220.9M | $193.5M | $158.7M | $200.7M | |
Current Portion Of Long-Term Debt | $12.3M | $10.4M | $12M | -- | -- | |
Current Portion Of Capital Lease Obligations | $18.3M | $22M | $26.8M | $48.8M | $61.9M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $450.1M | $496.1M | $488.4M | $466.7M | $543.3M | |
Long-Term Debt | $1.1B | $1.1B | $1.3B | $888.1M | $802.5M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.8B | $1.9B | $2.1B | $1.6B | $1.6B | |
Common Stock | $1M | $1.1M | $1.1M | $499.3M | $508.2M | |
Other Common Equity Adj | -- | -- | $2M | $17.1M | -$1.5M | |
Common Equity | $1.3B | $1.3B | $1.2B | $1.2B | $1.3B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.3B | $1.3B | $1.2B | $1.7B | $1.8B | |
Total Liabilities and Equity | $3.1B | $3.2B | $3.3B | $3.4B | $3.4B | |
Cash and Short Terms | $157.1M | $123.7M | $20.1M | $67M | $140.4M | |
Total Debt | $1.1B | $1.1B | $1.3B | $888.1M | $802.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $123.8M | $45.5M | $11M | $177.3M | $141.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $376.4M | $411.4M | $413.1M | $420.8M | $394.9M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $61.1M | $110M | $108.9M | $88.3M | $87.8M | |
Total Current Assets | $635.7M | $664M | $653.4M | $798.6M | $715.5M | |
Property Plant And Equipment | $326.9M | $381.3M | $413.8M | $388.2M | $480.3M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $1.9B | $2B | $2B | $2B | $2B | |
Other Intangibles | $214.1M | $189M | $153.8M | $112.7M | $80.6M | |
Other Long-Term Assets | $42.1M | $42.5M | $33.9M | $46.4M | $32.8M | |
Total Assets | $3.1B | $3.3B | $3.3B | $3.4B | $3.3B | |
Accounts Payable | $144.3M | $158.1M | $140.8M | $131.4M | $136.6M | |
Accrued Expenses | $206.8M | $203M | $183.3M | $164.4M | $177.9M | |
Current Portion Of Long-Term Debt | $10.4M | $10.4M | $12M | -- | -- | |
Current Portion Of Capital Lease Obligations | $20.8M | $24.8M | $27.3M | $25.3M | $24.7M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $508.9M | $525.7M | $502.2M | $477.2M | $504.8M | |
Long-Term Debt | $1.1B | $1.3B | $1.3B | $880.4M | $798.9M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.9B | $2B | $2.1B | $1.6B | $1.6B | |
Common Stock | $1.1M | $1.1M | $1.1M | $508.2M | $508.2M | |
Other Common Equity Adj | -- | -- | -$100K | $10.3M | $2.3M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.3B | $1.3B | $1.2B | $1.8B | $1.8B | |
Total Liabilities and Equity | $3.1B | $3.3B | $3.3B | $3.4B | $3.3B | |
Cash and Short Terms | $123.8M | $45.5M | $11M | $177.3M | $141.3M | |
Total Debt | $1.1B | $1.3B | $1.4B | $880.4M | $798.9M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$41.6M | $46.3M | $14M | -$7.7M | $66.4M | |
Depreciation & Amoritzation | $136.3M | $137M | $150.4M | $149.7M | $144.2M | |
Stock-Based Compensation | $23.6M | $19.7M | $18.9M | $22.1M | $20.2M | |
Change in Accounts Receivable | $18.6M | -$41.9M | -$6.3M | -$52.6M | $19.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $245.1M | $148.4M | $106.9M | $129.9M | $205.6M | |
Capital Expenditures | $52.7M | $61.2M | $107.3M | $71.3M | $78.4M | |
Cash Acquisitions | -$61.8M | -$107.7M | -$93.1M | -$13.8M | $51M | |
Cash From Investing | -$108.8M | -$158.7M | -$193.7M | -$61.4M | -$5.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$17.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $70M | $34.5M | $1.7B | $583M | $500K | |
Long-Term Debt Repaid | -$170.3M | -$55.5M | -$1.6B | -$1.1B | -$123.6M | |
Repurchase of Common Stock | -$1.5M | -$1.9M | -$163.8M | -$2.2M | -$3.1M | |
Other Financing Activities | $81.7M | -$2M | -$18.7M | -$24M | $14.4M | |
Cash From Financing | -$18.3M | -$23.1M | -$16.8M | -$21.6M | -$126.6M | |
Beginning Cash (CF) | $39.1M | $157.1M | $123.7M | $20.1M | $67M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $118M | -$33.4M | -$103.6M | $46.9M | $73.4M | |
Ending Cash (CF) | $157.1M | $123.7M | $20.1M | $67M | $140.4M | |
Levered Free Cash Flow | $192.4M | $87.2M | -$400K | $58.6M | $127.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $6.3M | $700K | -$22M | $33.7M | $6.4M | |
Depreciation & Amoritzation | $33.2M | $36.5M | $38.4M | $34.8M | $39M | |
Stock-Based Compensation | $5.3M | $4.6M | $6.3M | $4.9M | $4.6M | |
Change in Accounts Receivable | -$25.7M | -$14.8M | -$1.6M | -$4.2M | -$8.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $78.3M | $64.7M | $84.6M | $83.3M | $91.2M | |
Capital Expenditures | $18.2M | $35.6M | $15.5M | $12.6M | $33.6M | |
Cash Acquisitions | -$13.5M | -$78.4M | -$3.8M | $51.6M | -- | |
Cash From Investing | -$28.6M | -$112M | -$16.8M | $40.9M | -$28.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$9M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $24M | $152M | $136.5M | -- | $10M | |
Long-Term Debt Repaid | -$7.4M | -$103.7M | -$208M | -$8M | -$1M | |
Repurchase of Common Stock | -- | -$88.7M | -- | -- | -$1.7M | |
Other Financing Activities | -$24.6M | -- | -$8.1M | -$3.8M | -$18.7M | |
Cash From Financing | -$7.5M | -$40M | -$79.2M | -$11.4M | -$20.1M | |
Beginning Cash (CF) | $81.6M | $132.8M | $22.4M | $64.5M | $98.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $42.2M | -$87.3M | -$11.4M | $112.8M | $43M | |
Ending Cash (CF) | $123.8M | $45.5M | $11M | $177.3M | $141.3M | |
Levered Free Cash Flow | $60.1M | $29.1M | $69.1M | $70.7M | $57.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$14.2M | $39.9M | -$14.8M | $50.5M | $45.1M | |
Depreciation & Amoritzation | $138.4M | $139.6M | $156.5M | $142.8M | $151.2M | |
Stock-Based Compensation | $20.7M | $18.8M | $21.5M | $20.2M | $19.3M | |
Change in Accounts Receivable | -$38.2M | -$12.3M | -$4.4M | -$18.6M | $14.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $242.8M | $107.3M | $119.6M | $184.4M | $247.8M | |
Capital Expenditures | $45.5M | $97.5M | $85.8M | $51.3M | $148M | |
Cash Acquisitions | -$50.4M | -$116.4M | -$22.5M | $51.6M | -$600K | |
Cash From Investing | -$89.9M | -$204.4M | -$99.8M | $22.7M | -$121.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$35.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $24M | $237.5M | $1.8B | $252M | $11.6M | |
Long-Term Debt Repaid | -$165.9M | -$153.4M | -$1.8B | -$765.9M | -$135.7M | |
Repurchase of Common Stock | -$2.6M | -$91.6M | -$74.2M | -$3.5M | -$7.4M | |
Other Financing Activities | $24.7M | -- | -$28.3M | -$19.5M | $600K | |
Cash From Financing | -$117.1M | $18.8M | -$54.3M | -$40.8M | -$162.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $35.8M | -$78.3M | -$34.5M | $166.3M | -$36M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $197.3M | $9.8M | $33.8M | $133.1M | $99.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$5.7M | -$12.1M | -$40.9M | $17.3M | -$4M | |
Depreciation & Amoritzation | $68.7M | $71.3M | $77.4M | $70.5M | $77.5M | |
Stock-Based Compensation | $10.2M | $9.3M | $11.9M | $10M | $9.1M | |
Change in Accounts Receivable | -$48.7M | -$19.1M | -$17.2M | $16.8M | $11.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $83.4M | $42.3M | $55M | $109.5M | $151.7M | |
Capital Expenditures | $27.9M | $64.2M | $42.7M | $22.7M | $92.3M | |
Cash Acquisitions | -$75.7M | -$84.4M | -$13.8M | $51.6M | -- | |
Cash From Investing | -$100M | -$145.7M | -$51.8M | $32.3M | -$83.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$18M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $24M | $227M | $331.5M | $500K | $11.6M | |
Long-Term Debt Repaid | -$14M | -$111.9M | -$333.7M | -$25M | -$37.1M | |
Repurchase of Common Stock | -$1.1M | -$90.8M | -$1.2M | -$2.5M | -$6.8M | |
Other Financing Activities | -$26.6M | -- | -$9.6M | -$5.1M | -$18.9M | |
Cash From Financing | -$16.7M | $25.2M | -$12.3M | -$31.5M | -$67.4M | |
Beginning Cash (CF) | $238.7M | $256.5M | $42.5M | $131.5M | $238.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$33.3M | -$78.2M | -$9.1M | $110.3M | $900K | |
Ending Cash (CF) | $205.4M | $178.3M | $33.4M | $241.8M | $239.6M | |
Levered Free Cash Flow | $55.5M | -$21.9M | $12.3M | $86.8M | $59.4M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.